+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Plasma Fractionation Market by Product (Albumin, Coagulation Factor Concentrates, Immunoglobulin), Application (Critical Care, Hemato-Oncology, Hematology), End-User - Forecast 2024-2030- Product Image
Global Plasma Fractionation Market by Product (Albumin, Coagulation Factor Concentrates, Immunoglobulin), Application (Critical Care, Hemato-Oncology, Hematology), End-User - Forecast 2024-2030- Product Image
Sale

Global Plasma Fractionation Market by Product (Albumin, Coagulation Factor Concentrates, Immunoglobulin), Application (Critical Care, Hemato-Oncology, Hematology), End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 182 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5336507
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Plasma Fractionation Market size was estimated at USD 35.52 billion in 2023, USD 38.95 billion in 2024, and is expected to grow at a CAGR of 10.45% to reach USD 71.27 billion by 2030.

Plasma fractionation refers to collecting, separating, and purifying various essential components present in human plasma, primarily including albumin, immunoglobulins, coagulation factors, and other proteins. These components have many applications in medical treatments, such as hemophilia therapy, immunity disorders treatment, wound healing support, neurology therapy, and other rare diseases. The demand for source plasma has been steadily increasing due to its role as a vital ingredient in several life-saving therapies. This surge can be attributed to an aging population prone to chronic illnesses requiring blood-based therapies and the rising prevalence of immune disorders. In addition, rising awareness about blood-related diseases among patients contributes significantly to this market's expansion. However, stringent government regulations on plasma fractionation and the presence of alternative recombinant therapies may hamper the market demand. New advancements in production technology further boost opportunities for the players involved in this field. Moreover, strategic collaborations among various stakeholders drive innovative research work within the industry that provides novel solutions and is expected to create a lucrative market opportunity in the forecasted period.

Regional Insights

The Americas has a significant market presence in the plasma fractionation market due to a well-established healthcare infrastructure, high prevalence of immunodeficiency diseases, and an increasing geriatric population. In Europe, EU countries have a strong regulatory framework governing the plasma fractionation industry. The European Medicines Agency (EMA) regulates manufacturing practices and oversees quality standards for blood-derived products, significantly driving the region's market demand. The MEA region presents lucrative opportunities due to rising incomes and expanding access to healthcare services. The Asia-Pacific observed a developing landscape in the plasma fractionation market owing to rapid urbanization and economic development that is driving investments in healthcare infrastructure. Additionally, there is an increasing focus on blood safety regulations by governments in the APAC region, presenting opportunities for market players.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Plasma Fractionation Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Plasma Fractionation Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Plasma Fractionation Market, highlighting leading vendors and their innovative profiles. These include 3M Company, ADMA Biologics, Inc., Bharat Serums and Vaccines Limited, Bio Products Laboratory Ltd., Biotest AG by Grifols, S.A., China Biologic Products, Inc., CSL Limited, Emergent BioSolutions Inc., Fusion Health Care Pvt. Ltd., GC Biopharma corp., Grifols, S.A., HEINKEL Process Technology GmbH, Hemarus Therapeutics Ltd, Intas Pharmaceuticals Ltd., Kamada Ltd., Kedrion S.p.A., LFB SA, Merck KGaA, Octapharma AG, PlasmaGen BioSciences Pvt. Ltd., Prothya Biosolutions B.V., Sanquin, Shanghai Raas Blood Products Co. Ltd, SK Plasma Co.,Ltd., STERIS plc, and Takeda Pharmaceutical Company Ltd.

Market Segmentation & Coverage

This research report categorizes the Plasma Fractionation Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Albumin
    • Coagulation Factor Concentrates
      • Factor IX
      • Factor VIII
      • Factor XIII
      • Fibrinogen Concentrates
      • Prothrombin Complex Concentrate
      • Von Willebrand Factor
    • Immunoglobulin
      • Intravenous Immunoglobulin
      • Subcutaneous Immunoglobulin
    • Protease Inhibitors
  • Application
    • Critical Care
    • Hemato-Oncology
    • Hematology
    • Neurology
    • Pulmonology
    • Rheumatology
  • End-User
    • Academic & Research Institutes
    • Clinical Research Laboratories
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Plasma Fractionation Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Plasma Fractionation Market?
  3. What are the technology trends and regulatory frameworks in the Plasma Fractionation Market?
  4. What is the market share of the leading vendors in the Plasma Fractionation Market?
  5. Which modes and strategic moves are suitable for entering the Plasma Fractionation Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Plasma Fractionation Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Improving access to plasma-based therapies and high use of immunoglobulins in various therapeutic areas
5.1.1.2. Government initiatives to increase plasma collection
5.1.1.3. Growing prevalence of elderly people around the globe and the increasing number of blood collection facilities
5.1.2. Restraints
5.1.2.1. Presence of new pathogenic agents that resist the present viral inactivation treatments
5.1.3. Opportunities
5.1.3.1. Continuous advancements in process development technology for improved formulations
5.1.3.2. Exponential utilization in new clinical trials and growing R&D activities in plasma treatment
5.1.4. Challenges
5.1.4.1. Stringent government regulations on plasma fractionation and the presence of alternative recombinant therapies
5.2. Market Segmentation Analysis
5.2.1. Product: Rising use of plasma fractionation for immunoglobulins purification
5.2.2. Application: Proliferating use to treat hematological disorders
5.2.3. End-User: Extensive use of plasma fractionation in clinical research laboratories to ensure the safety and efficacy of plasma-derived products
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Plasma Fractionation Market, by Product
6.1. Introduction
6.2. Albumin
6.3. Coagulation Factor Concentrates
6.4.1. Factor IX
6.4.2. Factor VIII
6.4.3. Factor XIII
6.4.4. Fibrinogen Concentrates
6.4.5. Prothrombin Complex Concentrate
6.4.6. Von Willebrand Factor
6.4. Immunoglobulin
6.5.1. Intravenous Immunoglobulin
6.5.2. Subcutaneous Immunoglobulin
6.5. Protease Inhibitors
7. Plasma Fractionation Market, by Application
7.1. Introduction
7.2. Critical Care
7.3. Hemato-Oncology
7.4. Hematology
7.5. Neurology
7.6. Pulmonology
7.7. Rheumatology
8. Plasma Fractionation Market, by End-User
8.1. Introduction
8.2. Academic & Research Institutes
8.3. Clinical Research Laboratories
9. Americas Plasma Fractionation Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Plasma Fractionation Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Plasma Fractionation Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
12.3.1. Agreement, Collaboration, & Partnership
12.3.1.1. Grifols Egypt delivers first plasma medicines made from Egyptian plasma donations
12.3.2. New Product Launch & Enhancement
12.3.2.1. Kedrion presented at plasma fractionation workshop in Saudi Arabia
12.3.3. Award, Recognition, & Expansion
12.3.3.1. CSL's USD470 Million Plasma Fractionation Facility Opens in Marburg, Germany
12.3.3.2. Takeda to Invest 100 Billion JPY in a New Manufacturing Facility for Plasma-Derived Therapies in Japan
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. 3M Company
13.1.2. ADMA Biologics, Inc.
13.1.3. Bharat Serums and Vaccines Limited
13.1.4. Bio Products Laboratory Ltd.
13.1.5. Biotest AG by Grifols, S.A.
13.1.6. China Biologic Products, Inc.
13.1.7. CSL Limited
13.1.8. Emergent BioSolutions Inc.
13.1.9. Fusion Health Care Pvt. Ltd.
13.1.10. GC Biopharma corp.
13.1.11. Grifols, S.A.
13.1.12. HEINKEL Process Technology GmbH
13.1.13. Hemarus Therapeutics Ltd
13.1.14. Intas Pharmaceuticals Ltd.
13.1.15. Kamada Ltd.
13.1.16. Kedrion S.p.A.
13.1.17. LFB SA
13.1.18. Merck KGaA
13.1.19. Octapharma AG
13.1.20. PlasmaGen BioSciences Pvt. Ltd.
13.1.21. Prothya Biosolutions B.V.
13.1.22. Sanquin
13.1.23. Shanghai Raas Blood Products Co. Ltd
13.1.24. SK Plasma Co.,Ltd.
13.1.25. STERIS plc
13.1.26. Takeda Pharmaceutical Company Ltd
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. PLASMA FRACTIONATION MARKET RESEARCH PROCESS
FIGURE 2. PLASMA FRACTIONATION MARKET SIZE, 2023 VS 2030
FIGURE 3. PLASMA FRACTIONATION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. PLASMA FRACTIONATION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. PLASMA FRACTIONATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. PLASMA FRACTIONATION MARKET DYNAMICS
FIGURE 7. PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. PLASMA FRACTIONATION MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. PLASMA FRACTIONATION MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. PLASMA FRACTIONATION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. PLASMA FRACTIONATION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. PLASMA FRACTIONATION MARKET SIZE, BY ALBUMIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 9. PLASMA FRACTIONATION MARKET SIZE, BY FACTOR IX, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. PLASMA FRACTIONATION MARKET SIZE, BY FACTOR VIII, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. PLASMA FRACTIONATION MARKET SIZE, BY FACTOR XIII, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. PLASMA FRACTIONATION MARKET SIZE, BY FIBRINOGEN CONCENTRATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. PLASMA FRACTIONATION MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. PLASMA FRACTIONATION MARKET SIZE, BY VON WILLEBRAND FACTOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 17. PLASMA FRACTIONATION MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. PLASMA FRACTIONATION MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. PLASMA FRACTIONATION MARKET SIZE, BY PROTEASE INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 21. PLASMA FRACTIONATION MARKET SIZE, BY CRITICAL CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. PLASMA FRACTIONATION MARKET SIZE, BY HEMATO-ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. PLASMA FRACTIONATION MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. PLASMA FRACTIONATION MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. PLASMA FRACTIONATION MARKET SIZE, BY PULMONOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. PLASMA FRACTIONATION MARKET SIZE, BY RHEUMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 28. PLASMA FRACTIONATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. PLASMA FRACTIONATION MARKET SIZE, BY CLINICAL RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 46. CANADA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 47. CANADA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 48. CANADA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 49. CANADA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. CANADA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 51. MEXICO PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 52. MEXICO PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 53. MEXICO PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 54. MEXICO PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. MEXICO PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 64. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 65. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 67. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 68. AUSTRALIA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 69. AUSTRALIA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 70. AUSTRALIA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 71. AUSTRALIA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. AUSTRALIA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 73. CHINA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 74. CHINA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 75. CHINA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 76. CHINA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. CHINA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. INDIA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 79. INDIA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 80. INDIA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 81. INDIA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. INDIA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 83. INDONESIA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 84. INDONESIA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 85. INDONESIA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 86. INDONESIA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. INDONESIA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 88. JAPAN PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 89. JAPAN PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 90. JAPAN PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 91. JAPAN PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. JAPAN PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. MALAYSIA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. MALAYSIA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 95. MALAYSIA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 96. MALAYSIA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. MALAYSIA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 98. PHILIPPINES PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 99. PHILIPPINES PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 100. PHILIPPINES PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 101. PHILIPPINES PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. PHILIPPINES PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 103. SINGAPORE PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 104. SINGAPORE PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 105. SINGAPORE PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 106. SINGAPORE PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. SINGAPORE PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 108. SOUTH KOREA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 109. SOUTH KOREA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 110. SOUTH KOREA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 111. SOUTH KOREA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. SOUTH KOREA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 113. TAIWAN PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 114. TAIWAN PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 115. TAIWAN PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 116. TAIWAN PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. TAIWAN PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 118. THAILAND PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 119. THAILAND PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 120. THAILAND PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 121. THAILAND PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. THAILAND PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 123. VIETNAM PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 124. VIETNAM PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 125. VIETNAM PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 126. VIETNAM PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. VIETNAM PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 134. DENMARK PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 135. DENMARK PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 136. DENMARK PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 137. DENMARK PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. DENMARK PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 139. EGYPT PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 140. EGYPT PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 141. EGYPT PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 142. EGYPT PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. EGYPT PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 144. FINLAND PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 145. FINLAND PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 146. FINLAND PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 147. FINLAND PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. FINLAND PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 149. FRANCE PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 150. FRANCE PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 151. FRANCE PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 152. FRANCE PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. FRANCE PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 154. GERMANY PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 155. GERMANY PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 156. GERMANY PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 157. GERMANY PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. GERMANY PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 159. ISRAEL PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 160. ISRAEL PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 161. ISRAEL PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 162. ISRAEL PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. ISRAEL PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 164. ITALY PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 165. ITALY PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 166. ITALY PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 167. ITALY PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. ITALY PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 169. NETHERLANDS PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 170. NETHERLANDS PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 171. NETHERLANDS PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 172. NETHERLANDS PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. NETHERLANDS PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 174. NIGERIA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 175. NIGERIA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 176. NIGERIA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 177. NIGERIA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. NIGERIA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 179. NORWAY PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 180. NORWAY PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 181. NORWAY PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 182. NORWAY PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. NORWAY PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 184. POLAND PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 185. POLAND PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 186. POLAND PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 187. POLAND PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. POLAND PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 189. QATAR PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 190. QATAR PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 191. QATAR PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 192. QATAR PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. QATAR PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 197. RUSSIA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 198. RUSSIA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 202. SAUDI ARABIA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 203. SAUDI ARABIA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 206. SOUTH AFRICA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. SOUTH AFRICA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 209. SPAIN PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 210. SPAIN PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 211. SPAIN PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 212. SPAIN PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 213. SPAIN PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 215. SWEDEN PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 216. SWEDEN PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 217. SWEDEN PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 218. SWEDEN PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 219. SWITZERLAND PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 220. SWITZERLAND PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 221. SWITZERLAND PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 222. SWITZERLAND PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 223. SWITZERLAND PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 224. TURKEY PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 225. TURKEY PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 226. TURKEY PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 227. TURKEY PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 228. TURKEY PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 236. UNITED KINGDOM PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 238. UNITED KINGDOM PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 239. PLASMA FRACTIONATION MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 240. PLASMA FRACTIONATION MARKET SHARE, BY KEY PLAYER, 2023
TABLE 241. PLASMA FRACTIONATION MARKET LICENSE & PRICING

Companies Mentioned

  • 3M Company
  • ADMA Biologics, Inc.
  • Bharat Serums and Vaccines Limited
  • Bio Products Laboratory Ltd.
  • Biotest AG by Grifols, S.A.
  • China Biologic Products, Inc.
  • CSL Limited
  • Emergent BioSolutions Inc.
  • Fusion Health Care Pvt. Ltd.
  • GC Biopharma corp.
  • Grifols, S.A.
  • HEINKEL Process Technology GmbH
  • Hemarus Therapeutics Ltd
  • Intas Pharmaceuticals Ltd.
  • Kamada Ltd.
  • Kedrion S.p.A.
  • LFB SA
  • Merck KGaA
  • Octapharma AG
  • PlasmaGen BioSciences Pvt. Ltd.
  • Prothya Biosolutions B.V.
  • Sanquin
  • Shanghai Raas Blood Products Co. Ltd
  • SK Plasma Co.,Ltd.
  • STERIS plc
  • Takeda Pharmaceutical Company Ltd

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages182
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 38.95 Billion
Forecasted Market Value ( USD ) by 2030 $ 71.27 Billion
Compound Annual Growth Rate10.4%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Global Plasma Fractionation Market by Product (Immunoglobulins, Albumin, Protease Inhibitors, von Willebrand Factor, PCC), Application (Neurology, Immunology, Hematology, Rheumatology), End User (Clinical Research, Hospitals & Clinics) - Forecast to 2028 - Product Image

Global Plasma Fractionation Market by Product (Immunoglobulins, Albumin, Protease Inhibitors, von Willebrand Factor, PCC), Application (Neurology, Immunology, Hematology, Rheumatology), End User (Clinical Research, Hospitals & Clinics) - Forecast to 2028

  • Report
  • 374 Pages
  • Global
From
Plasma Fractionation Market by Type of Company, Scale of Operation, Type of Plasma-derived Therapeutic Products Manufactured, Therapeutic Areas of Plasma-derived Products and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035 - Product Image

Plasma Fractionation Market by Type of Company, Scale of Operation, Type of Plasma-derived Therapeutic Products Manufactured, Therapeutic Areas of Plasma-derived Products and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035

  • Report
  • 190 Pages
  • Global
From
Plasma Fractionation Global Market Report 2024 - Product Image

Plasma Fractionation Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Plasma Fractionation: Global Strategic Business Report - Product Image

Plasma Fractionation: Global Strategic Business Report

  • Report
  • 197 Pages
  • Global
From
Global Plasma Fractionation Market Report and Forecast 2023-2031 - Product Image

Global Plasma Fractionation Market Report and Forecast 2023-2031

  • Report
  • 147 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.